First report on the targeted therapy of an IDH1-mutated Cholangiocarcinoma in a patient with Maffucci syndrome

被引：0
|
作者：
Peters, M. [1 ]
Lessel, D. [2 ]
Bernreuther, C. [3 ]
Iglauer, P. [3 ]
Heukamp, L. [4 ]
Velthaus, J. -L. [1 ]
Bokemeyer, C. [1 ]
Sonja, L. [1 ]
Volk, A. [2 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, Med Klin & Poliklin 2, Hamburg, Germany
[2] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, Hamburg, Germany
[3] Univ Klinikum Hamburg Eppendorf UKE, Hamburg, Germany
[4] Inst Hamatopathol Hamburg, Hamburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / SUPPL 4期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
426
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [41] Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1-mutated or IDH2-mutated solid tumours
    Molenaar, Remco J.
    Coelen, Robert J. S.
    Khurshed, Mohammed
    Roos, Eva
    Caan, Matthan W. A.
    van Linde, Myra E.
    Kouwenhoven, Mathilde
    Bramer, Jos A. M.
    Bovee, Judith V. M. G.
    Mathot, Ron A.
    Klumpen, Heinz-Josef
    van Laarhoven, Hanneke W. M.
    van Noorden, Cornelis J. F.
    Vandertop, W. Peter
    Gelderblom, Hans
    van Gulik, Thomas M.
    Wilmink, Johanna W.
    BMJ OPEN, 2017, 7 (06):
  • [42] The mRNA-binding protein HuR, regulates mutant and wild type IDH1 expression in IDH1-mutated cancer
    Zarei, Mahsa
    Lal, Shruti
    Mambelli-Lisboa, Nicole C.
    Cheung, Edwin
    Chand, Saswati N.
    Yeo, Charles J.
    Brody, Jonathan R.
    Winter, Jordan M.
    CANCER RESEARCH, 2016, 76
  • [43] Recurrent somatic IDH1 mutation in an adult with Maffucci syndrome
    Brown, N. J.
    Ye, Z.
    Stutterd, C.
    Schneider, A.
    Mullen, S.
    Mandelstam, S.
    Scheffer, I. E.
    Hildebrand, M. S.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1286 - 1286
  • [44] Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL
    Karpel-Massler, Georg
    Ishida, Chiaki Tsuge
    Bianchetti, Elena
    Zhang, Yiru
    Shu, Chang
    Tsujiuchi, Takashi
    Banu, Matei A.
    Garcia, Franklin
    Roth, Kevin A.
    Bruce, Jeffrey N.
    Canoll, Peter
    Siegelin, Markus D.
    NATURE COMMUNICATIONS, 2017, 8
  • [45] Disruption of Wild-Type IDH1 Suppresses D-2-Hydroxyglutarate Production in IDH1-Mutated Gliomas
    Jin, Genglin
    Reitman, Zachary J.
    Duncan, Christopher G.
    Spasojevic, Ivan
    Gooden, David M.
    Rasheed, B. Ahmed
    Yang, Rui
    Lopez, Giselle Y.
    He, Yiping
    McLendon, Roger E.
    Bigner, Darell D.
    Yan, Hai
    CANCER RESEARCH, 2013, 73 (02) : 496 - 501
  • [46] Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial
    Watts, Justin M.
    Baer, Maria R.
    Yang, Jay
    Prebet, Thomas
    Lee, Sangmin
    Schiller, Gary J.
    Dinner, Shira N.
    Pigneux, Arnaud
    Montesinos, Pau
    Wang, Eunice S.
    Seiter, Karen P.
    Wei, Andrew H.
    De Botton, Stephane
    Arnan, Montserrat
    Donnellan, Will
    Schwarer, Anthony P.
    Recher, Christian
    Jonas, Brian A.
    Ferrell Jr, P. Brent
    Marzac, Christophe
    Kelly, Patrick
    Sweeney, Jennifer
    Forsyth, Sanjeev
    Guichard, Sylvie M.
    Brevard, Julie
    Henrick, Patrick
    Mohamed, Hesham
    Cortes, Jorge E.
    LANCET HAEMATOLOGY, 2023, 10 (01): : E46 - E58
  • [47] Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL
    Georg Karpel-Massler
    Chiaki Tsuge Ishida
    Elena Bianchetti
    Yiru Zhang
    Chang Shu
    Takashi Tsujiuchi
    Matei A. Banu
    Franklin Garcia
    Kevin A. Roth
    Jeffrey N. Bruce
    Peter Canoll
    Markus D. Siegelin
    Nature Communications, 8
  • [48] A Phase Ib Clinical Trial of Metformin and Chloroquine in Patients with IDH1-Mutated Solid Tumors
    Khurshed, Mohammed
    Molenaar, Remco J.
    van Linde, Myra E.
    Mathot, Ron A.
    Struys, Eduard A.
    van Wezel, Tom
    van Noorden, Cornelis J. F.
    Kluempen, Heinz-Josef
    Bovee, Judith V. M. G.
    Wilmink, Johanna W.
    CANCERS, 2021, 13 (10)
  • [49] Chemosensitivity of IDH1-Mutated Gliomas Due to an Impairment in PARP1-Mediated DNA Repair
    Lu, Yanxin
    Kwintkiewicz, Jakub
    Liu, Yang
    Tech, Katherine
    Frady, Lauren N.
    Su, Yu-Ting
    Bautista, Wendy
    Moon, Seog In
    MacDonald, Jeffrey
    Ewend, Matthew G.
    Gilbert, Mark R.
    Yang, Chunzhang
    Wu, Jing
    CANCER RESEARCH, 2017, 77 (07) : 1709 - 1718
  • [50] Potential utility of MCL-1 inhibitor for IDH1-mutated biliary tract cancer: analysis using patient-derived organoids
    Suzuki, Shiho
    Matsuzaki, Juntaro
    Saito, Yoshimasa
    CANCER SCIENCE, 2024, 115 : 1534 - 1534
12345